Clinical Trials
3
Active:1
Completed:0
Trial Phases
1 Phases
Not Applicable:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Not Applicable
3 (100.0%)Using Signos mHealth Platform in Adults for Weight Management
Not Applicable
Active, not recruiting
- Conditions
- Metabolic SyndromeWeight LossOverweight and Obesity
- First Posted Date
- 2024-01-19
- Last Posted Date
- 2024-10-08
- Lead Sponsor
- Signos Inc
- Target Recruit Count
- 380
- Registration Number
- NCT06214221
- Locations
- 🇺🇸
Helios Clinical Research (Phoenix), Phoenix, Arizona, United States
🇺🇸Diablo Clinical Research, Walnut Creek, California, United States
🇺🇸Segal Trials, North Miami, Florida, United States
Signos DM2 Empowerment Study (SIGNOS-CGM-EMPOWER-201-2022)
Not Applicable
Recruiting
- Conditions
- Central ObesityMetabolic Glucose DisordersWeight LossMetabolic SyndromeGlucose IntoleranceDiabetes Mellitus, Type 2Insulin Resistance
- First Posted Date
- 2023-05-25
- Last Posted Date
- 2024-01-12
- Lead Sponsor
- Signos Inc
- Target Recruit Count
- 20000
- Registration Number
- NCT05874635
- Locations
- 🇺🇸
Signos, Palo Alto, California, United States
Use of Continuous Glucose Monitoring in Non-Diabetic Population to Compliment Signos Mobile Health Platform
Not Applicable
Recruiting
- Conditions
- Pre-diabetesMetabolic SyndromeGlucose IntoleranceWeight LossCentral ObesityMetabolic Glucose Disorders
- First Posted Date
- 2021-11-16
- Last Posted Date
- 2024-06-13
- Lead Sponsor
- Signos Inc
- Target Recruit Count
- 100000
- Registration Number
- NCT05121844
- Locations
- 🇺🇸
Signos, Palo Alto, California, United States
News
No news found